Title: Study of the Incidence of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus and Ischeamic Heart Disease
Authors: Dr Debapriya Datta, Dr O K Radhakrishnan, Dr Madhuri Sarkar, Dr Priti
DOI: http://dx.doi.org/10.18535/jmscr/v4i6.50
Introduction: Diabetes mellitus (DM) is a metabolic disorder characterised by raised blood glucose level and diabetic retinopathy is a vascular disorder which affects the microvasculature of the retina. Diabetic retinopathy can occur in both type 1 and type 2 DM . Type2 DM is a very important independent risk factor for development of cardiovascular disease, stroke, peripheral arterial disease, cardiomyopathy and congestive heart failure (CHF). These macrovasular complications are one of the leading causes of deaths in the world. The impact of glycaemic control in reducing micro vascular complications has been well established. Although controversial, there is evidence that glycaemic control can limit macrovasular disease including cardiovascular disease, stroke and peripheral arterial disease. The purpose of doing the study is to find out if there is a greater occurrence of Ischaemic Heart Disease (IHD) in patients of diabetic retinopathy and if the more severe stages of diabetic retinopathy are associated with increased occurrence of IHD. Since IHD is a macrovascular complication of DM and diabetic retinopathy is a microvascular complication of DM, we would like to know if there is a correlation between the two. Aims And Objective 1. Study the incidence of diabetic retinopathy in patients with type 2 DM 2. Study the incidence of diabetic retinopathy in patients with type 2 DM and ischemic heart disease 3. Establish relationship between diabetic retinopathy and ischemic heart disease 4. Establish if DR is a valid predictor of ischemic heart disease Materials And Method: A cross sectional observational study was conducted in Padmashree. DR. D. Y. Patil medical college, hospital and research center, Pimpri, Pune after the approval by institutional ethical committee. A total of 320 patients were studied. Inclusion criteria Patients of age between 40 to 70 years with h/o type2 DM for at least 5 years duration and ECG evidence of IHD. Exclusion criteria patients with any other systemic illness, patients with hazy media preventing visualisation of fundus, myopia, h/o eye surgery , h/o laser photocoagulation or any other ocular pathology. The selected patients were divided into 2 groups: Group A: 50 eyes of type 2 DM with diabetic retinopathy but without IHD Group B:50 eyes of type 2 DM with diabetic retinopathy and with IHD HBA1C, blood urea, serum creatinine, serum lipids and BP was recorded for all patients. Conclusion: In our study, we found the incidence of diabetic retinopathy to be 14.2%.there was no significant difference in the types of retinopathy between the two study groups. there was no significant difference between sex distributions in both groups. there was no significant difference in age amongst the two groups. Keywords: Diabetic retinopathy, Type 2 diabetes mellitus, Ischaemic heart disease, blood glucose, HbA1c 1. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, et al. Diabetic retinopathy. Diabetes Care 1998; 21 : 143-56. 2. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102 : 520-6. 3. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102 : 527-32. 4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes, estima-tes for the year 2000 and projections for 2030. Diabetes Care 2004; 27 : 1047-53. 5. Chan J C, Malik V, Jia W et al. diabetes in asia: epidemiology, risk factors and pathophysiology. JAMA 2009;301(20): 2129-2140 6. Mohamed Q, Gillies M C, Wong T Y. management of diabetic retinopathy: a systemic review, JAMA 2007; 298(8):902-916 7. Rema M, Sujatha P, Pradeepa R. Visual outcomes of panretinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors. Indian J Ophthalmol 2005; 53 : 93-9. 8. Kohner EM. Diabetic retinopathy. Br Med Bull 1989; 45 : 148-73. 9. Hertzel C et al. diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trail. USA 2013; 2337(10):dc12-12311 10. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I. Invest Ophthalmol Vis Sci 2005; 46 : 2328-33 11. Klein R, Davis MD, Moss SE, Klein BE, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy (WEDSR). A comparison of retinopathy in younger and older onset diabetic persons. Adv Exp Med Biol 1985; 189 : 321-35. 12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352 : 837-53. 13. Fawzia El Demerdash, Wael Refaie, Rashid Allakany, Salah Tantawy, Eid Dawood : Diabetic Retinopathy: a predictor of coronary heart disease. 2011. 08. 006 14. Ning Cheung, Jin Jin Wang, Ronald Klein, David J Couper, A. Richey Sharrett, Tein Y. Wong : Diabetic Retinopathy and the risk of Coronary Heart Disease. Diabetes care :July 2007 vol. 30 no. 7: 1742-1746 15. Ferris FL 3rd, Chew KY, Hoogwerf BJ. Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group ( EDTRS) . Diabetes Care 1996; 19 :1291-3.Abstract
References